IMAB - I-Mab - ADR
IEX Last Trade
1.135
0.015 1.322%
Share volume: 206,092
Last Updated: Fri 30 Aug 2024 09:54:08 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.12
0.02
1.34%
Summary score
25%
Profitability
25%
Dept financing
7%
Liquidity
44%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.41%
Return on assets
-16.95%
Return on sales
0%
Return on invested capital
219.55%
Total debt ratio
29.88%
Debt ratio change over timeo
0%
Current Ratio
3.15%
Quick Ratio
0%
Cash Position Ratio
2.72%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.41%
Return on assets
-16.95%
Return on sales
0%
Return on invested capital
219.55%
Total debt ratio
29.88%
Debt ratio change over timeo
0%
Current Ratio
3.15%
Quick Ratio
0%
Cash Position Ratio
2.72%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-19.41%
Return on assets
-16.95%
Return on sales
0%
Return on invested capital
219.55%
Total debt ratio
29.88%
Debt ratio change over time
0%
Current Ratio
3.15%
Quick Ratio
0%
Cash Position Ratio
2.72%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMAB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.41% | 5.89% | 9.6% | 6.01% |
| Return on assets | -16.95% | 3.81% | 3.52% | 5.45% |
| Return on sales | 0% | 33.24% | 43.6% | 33.16% |
| Return on invested capital | 219.55% | 4.43% | 8.45% | 11.66% |
| Profitability | 25% | 52% | 67% | 61% |
| Total debt ratio | 29.88% | 99.62% | 70.37% | 29.84% |
| Debt ratio change over time | 0% | 15.49% | 5.02% | 1.76% |
| Dept financing | 7% | 50% | 26% | 10% |
| Current Ratio | 3.15% | 1.02% | 2.84% | 4.24% |
| Quick Ratio | 0% | 0.91% | 2.57% | 3.46% |
| Cash Position Ratio | 2.72% | 0.44% | 0.67% | 1.82% |
| Liquididy | 44% | 21% | 55% | 55% |
| Short-term ratios | IMAB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.41% | -10.21% | 18% | 5.65% |
| Return on assets | -16.95% | 3.12% | 3.99% | 4.39% |
| Return on sales | 0% | 21.95% | 42.62% | 29.42% |
| Return on invested capital | 219.55% | 3.21% | 12.03% | 12.26% |
| Profitability | 25% | 31% | 74% | 52% |
| Total debt ratio | 29.88% | 114.21% | 81.93% | 25.62% |
| Debt ratio change over time | 0% | 17.86% | 5.8% | 2.14% |
| Dept financing | 7% | 50% | 26% | 9% |
| Current Ratio | 3.15% | 1.02% | 2.84% | 4.24% |
| Quick Ratio | 0% | 0.91% | 2.57% | 3.46% |
| Cash Position Ratio | 2.72% | 0.44% | 0.67% | 1.82% |
| Liquididy | 44% | 17% | 41% | 67% |